Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2005
11/02/2005CN1225279C Leukemia therapeutic pharmaceuticals
11/02/2005CN1225262C Chinese medicine capsule for treating hemopathy and its prepn.
11/02/2005CN1225258C Chinese medicine compound preparation for treating pancreatic cancer
11/02/2005CN1225248C Antineoplastic effect of a group of cycloart-one triterpene compound
11/02/2005CN1225242C Erianin fat emulsion as antineoplastic medicine and preparing process thereof
11/01/2005US6960685 histone deacetylase; antiproliferative agents; psoriasis, cancer; N-Hydroxy-2-(4-Isopropyl-phenylcarbamoyl)-methoxy)-acetamide
11/01/2005US6960650 Nucleotide sequences coding proteins for use in the treatment of tumors
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960597 Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
11/01/2005US6960591 Propane-1,3-dione derivative
11/01/2005US6960590 Orally active salts with tyrosine kinase activity
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960586 Having a steroid C17,20-lyase inhibitory activity; useful as prophylactic or therapeutic agent for prostate and breast cancers
11/01/2005US6960585 For therapy of inflammatory and immune diseases
11/01/2005US6960584 Inhibitors of Akt activity
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005US6960474 Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator
11/01/2005US6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960441 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and infections; for use as cosmetic, pesticide and antibiotic
11/01/2005US6960434 Forming embryonic germ cells useful as model for studying imprinting; mate mammals, obtain embryo, dissociate embryonic cells, culturing the dissociated cells
11/01/2005US6960352 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
10/2005
10/27/2005WO2005100987A1 Novel ligand of g protein coupled receptor protein and use thereof
10/27/2005WO2005100581A1 Novel isochroman compound and use thereof in anticancer agent, etc.
10/27/2005WO2005100567A1 Gene encoding guanine nucleotide exchange factor and its gene product
10/27/2005WO2005100562A1 OSTEOPONTIN siRNA
10/27/2005WO2005100560A1 Cell death inducer
10/27/2005WO2005100558A1 Cd40 ligand mutant and utilization of the same
10/27/2005WO2005100404A1 Prostate cancer diagnosis and treatment
10/27/2005WO2005100374A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1
10/27/2005WO2005100356A1 Inhibitors of akt activity
10/27/2005WO2005100341A1 2-aminopyridine derivative
10/27/2005WO2005099759A1 Medicine for prevention and/or treatment of arteriosclerosis
10/27/2005WO2005099738A1 Laminaria algal extract for use as a therapeutic agent
10/27/2005WO2005099736A1 Antitumor remedy
10/27/2005WO2005099686A1 Edible composition having effects of promoting the production and release of calcitonin gene-related peptide
10/27/2005WO2005023299A3 Therapeutic human anti-mhc class ii antibodies and their uses
10/27/2005WO2005007699A8 Human antibody molecules for il-13
10/27/2005WO2004073648A3 Composition and methods for inhibiting cell survival
10/27/2005WO2004072284A8 Modulation of insulin like growth factor i receptor expression
10/27/2005WO2003072595A3 Methods and products based on oligomerization of stress proteins
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050240017 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss
10/27/2005US20050240009 T-cell epitopes in staphylococcal enterotoxin b
10/27/2005US20050240008 Novel protein, dna thereof and process for producing the same
10/27/2005US20050240006 Cytoplasmic region with more than 107 or less than 104 amino acids, a transmembrance region, and an extracellular region; nucleic acids and antibodies; diagnosing hematopoietic cell malignancy or autoimmune disease
10/27/2005US20050239872 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
10/27/2005US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents
10/27/2005US20050239862 Amino ceramide-like compounds and therapeutic methods of use
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239855 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239835 controlling weight gain; 1-(1-amino-2-phenylethylcarbonyl)-4-cyclohexylpiperidine compounds
10/27/2005US20050239824 Triple monoamine reuptake inhibitors for the treatment of chronic pain
10/27/2005US20050239822 Substituted C-imiadazol[1,2-a] pyridin-3-yl-methylamines
10/27/2005US20050239815 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor
10/27/2005US20050239804 Method for improved chemical synthesis of guanidinium alkaloids
10/27/2005US20050239796 tert-butyl4-{(3,4-dimethoxyphenethyl)[2-(1H-indol-3-yl)acetyl]amino}-1-piperidine carboxylate; somatostatin receptors modulator; anticarcinogenic agent; acromegalia, hypophyseal adenomas, endocrine gastroenteropancreatic tumors including carcinoid syndrome; reducing amination of N-substituted piperidone
10/27/2005US20050239784 3-Phenyl analogs of toxoflavine as kinase inhibitors
10/27/2005US20050239781 For therapy of inflammatory disease and cancer
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005US20050239765 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239720 Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
10/27/2005US20050239718 Use of hederagenin 3-O-alpha-L-rhamnopyranosyl((1-2)-[betha-D-glucopyranosyl(1-4)]-alpha-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
10/27/2005US20050239716 2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}-alkylboronic acid derivatives
10/27/2005US20050239713 Novel tubulysin analogues
10/27/2005US20050239712 Pharmaceutically active compound
10/27/2005US20050239708 Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
10/27/2005US20050239694 Cyclic depsipeptide as chemotherapeutic anticancer agent
10/27/2005US20050239692 Aqueous preparation containing oligopeptides and etherified cyclodextrin
10/27/2005US20050239202 Methods and compositions for inhibiting the function of polynucleotide sequences
10/27/2005US20050239131 Interactive system for presenting and eliminating substances
10/27/2005US20050239099 27 human secreted proteins
10/27/2005US20050239051 Use of isogenic human cancer cells for high-throughput screening and drug discovery
10/27/2005US20050238706 Pharmaceutically active lipid based formulation of SN-38
10/27/2005US20050238660 Cpg formulations and related methods
10/27/2005US20050238652 Human lung adenocarcinoma-related monoclonal antibody and antigen and immunaossay method which uses the same
10/27/2005US20050238642 Modified bouganin proteins, cytotoxins and methods and uses thereof
10/27/2005US20050238637 Vectors for molecule delivery to CD11b expressing cells
10/27/2005US20050238634 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
10/27/2005US20050238578 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders
10/27/2005DE19964269B4 Verfahren zur Detektion des Proliferationspotentials von Zellen A process for the detection of the proliferation potential of cells
10/27/2005CA2606138A1 Prostate cancer diagnosis and treatment
10/27/2005CA2564878A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1
10/27/2005CA2562892A1 Bob-1 specific t cells and methods to use
10/27/2005CA2562890A1 Novel g-csf conjugates
10/27/2005CA2562617A1 (poly)aminoalkylaminoacetamide derivatives of epipodophyllotoxin, their process of preparation and their applications in therapeutics as anticancer agents
10/27/2005CA2562602A1 2-aminopyridine derivative
10/27/2005CA2561904A1 Mitotic kinesin inhibitors
10/27/2005CA2561315A1 Inhibitors of akt activity
10/26/2005EP1589108A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/26/2005EP1589107A1 Immunoglobulins devoid of light chains
10/26/2005EP1589099A1 Immortalized natural killer cell line
1 ... 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 ... 2211